REPORT ID 943

Asia-Pacific RNAi for Therapeutic Market Report 2019

Publish Date
2019
Pages
111
Format
Electronic (PDF)

In this report, the Asia-Pacific RNAi for Therapeutic market is valued at USD   XX million in 2019 and is expected to reach USD  XX million by the end of 2025, growing at a CAGR of  XX% between 2019 and 2025.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of RNAi for Therapeutic for these regions, from   2019 to 2025 (forecast), including
    China
    Japan
    South Korea
    Taiwan
    India
    Southeast Asia
    Australia

Asia-Pacific RNAi for Therapeutic market competition by top manufacturers/players, with RNAi for Therapeutic sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Alnylam Pharmaceuticals
    Arbutus Biopharma (Tekmira)
    Arrowhead Research
    Dicerna Pharmaceuticals
    Mirna Therapeutics
    Quark Pharmaceuticals
    RXi Pharmaceuticals
    Silence Therapeutics
    Benitec Biopharma
    Miragen Therapeutics
    Sylentis
    Gradalis
    Sirnaomics
    Silenseed
    Arcturus Therapeutics
    Ariz Biopharma
    Celsion Corporation
    Ascletis Pharmaceuticals

On the basis of product, this report displays the sales volum, revenue, product price, market share and growth rate of each type, primarily split into
    siRNA
    miRNA
    shRNA

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Cancer
    Cardiovascular
    HBV
    Other

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Asia-Pacific RNAi for Therapeutic Market  Report 2019
1 RNAi for Therapeutic Overview
    1.1 Product Overview and Scope of RNAi for Therapeutic
    1.2 Classification of RNAi for Therapeutic by Product Category
        1.2.1 Asia-Pacific RNAi for Therapeutic Market Size (Sales) Comparison by Types ( 2014-2024)
        1.2.2 Asia-Pacific RNAi for Therapeutic Market Size (Sales) Market Share by Type (Product Category)  in 2018
        1.2.3 siRNA
        1.2.4 miRNA
        1.2.5 shRNA
    1.3 Asia-Pacific RNAi for Therapeutic Market by Application/End Users
        1.3.1 Asia-Pacific RNAi for Therapeutic Sales (Volume) and Market Share Comparison by Applications ( 2014-2024)
        1.3.2 Cancer
        1.3.3 Cardiovascular
        1.3.4 HBV
        1.3.5 Other
    1.4 Asia-Pacific RNAi for Therapeutic Market by Region
        1.4.1 Asia-Pacific RNAi for Therapeutic Market Size (Value) Comparison by Region ( 2014-2024)
        1.4.2 China Status and Prospect ( 2014-2024)
        1.4.3 Japan Status and Prospect ( 2014-2024)
        1.4.4 South Korea Status and Prospect ( 2014-2024)
        1.4.5 Taiwan Status and Prospect ( 2014-2024)
        1.4.6 India Status and Prospect ( 2014-2024)
        1.4.7 Southeast Asia Status and Prospect ( 2014-2024)
        1.4.8 Australia Status and Prospect ( 2014-2024)
    1.5 Asia-Pacific Market Size (Value and Volume) of RNAi for Therapeutic ( 2014-2024)
        1.5.1 Asia-Pacific RNAi for Therapeutic Sales and Growth Rate ( 2014-2024)
        1.5.2 Asia-Pacific RNAi for Therapeutic Revenue and Growth Rate ( 2014-2024)

2 Asia-Pacific RNAi for Therapeutic Competition by Players/Suppliers, Region, Type and Application
    2.1 Asia-Pacific RNAi for Therapeutic Market Competition by Players/Suppliers
        2.1.1 Asia-Pacific RNAi for Therapeutic Sales Volume and Market Share of Key Players/Suppliers ( 2014-2019)
        2.1.2 Asia-Pacific RNAi for Therapeutic Revenue and Share by Players/Suppliers ( 2014-2019)
    2.2 Asia-Pacific RNAi for Therapeutic (Volume and Value) by Type
        2.2.1 Asia-Pacific RNAi for Therapeutic Sales and Market Share by Type ( 2014-2019)
        2.2.2 Asia-Pacific RNAi for Therapeutic Revenue and Market Share by Type ( 2014-2019)
    2.3 Asia-Pacific RNAi for Therapeutic (Volume) by Application
    2.4 Asia-Pacific RNAi for Therapeutic (Volume and Value) by Region
        2.4.1 Asia-Pacific RNAi for Therapeutic Sales and Market Share by Region ( 2014-2019)
        2.4.2 Asia-Pacific RNAi for Therapeutic Revenue and Market Share by Region ( 2014-2019)

3 China RNAi for Therapeutic (Volume, Value and Sales Price)
    3.1 China RNAi for Therapeutic Sales and Value ( 2014-2019)
        3.1.1 China RNAi for Therapeutic Sales Volume and Growth Rate ( 2014-2019)
        3.1.2 China RNAi for Therapeutic Revenue and Growth Rate ( 2014-2019)
        3.1.3 China RNAi for Therapeutic Sales Price Trend ( 2014-2019)
    3.2 China RNAi for Therapeutic Sales Volume and Market Share by Type
    3.3 China RNAi for Therapeutic Sales Volume and Market Share by Application

4 Japan RNAi for Therapeutic (Volume, Value and Sales Price)
    4.1 Japan RNAi for Therapeutic Sales and Value ( 2014-2019)
        4.1.1 Japan RNAi for Therapeutic Sales Volume and Growth Rate ( 2014-2019)
        4.1.2 Japan RNAi for Therapeutic Revenue and Growth Rate ( 2014-2019)
        4.1.3 Japan RNAi for Therapeutic Sales Price Trend ( 2014-2019)
    4.2 Japan RNAi for Therapeutic Sales Volume and Market Share by Type
    4.3 Japan RNAi for Therapeutic Sales Volume and Market Share by Application

5 South Korea RNAi for Therapeutic (Volume, Value and Sales Price)
    5.1 South Korea RNAi for Therapeutic Sales and Value ( 2014-2019)
        5.1.1 South Korea RNAi for Therapeutic Sales Volume and Growth Rate ( 2014-2019)
        5.1.2 South Korea RNAi for Therapeutic Revenue and Growth Rate ( 2014-2019)
        5.1.3 South Korea RNAi for Therapeutic Sales Price Trend ( 2014-2019)
    5.2 South Korea RNAi for Therapeutic Sales Volume and Market Share by Type
    5.3 South Korea RNAi for Therapeutic Sales Volume and Market Share by Application

6 Taiwan RNAi for Therapeutic (Volume, Value and Sales Price)
    6.1 Taiwan RNAi for Therapeutic Sales and Value ( 2014-2019)
        6.1.1 Taiwan RNAi for Therapeutic Sales Volume and Growth Rate ( 2014-2019)
        6.1.2 Taiwan RNAi for Therapeutic Revenue and Growth Rate ( 2014-2019)
        6.1.3 Taiwan RNAi for Therapeutic Sales Price Trend ( 2014-2019)
    6.2 Taiwan RNAi for Therapeutic Sales Volume and Market Share by Type
    6.3 Taiwan RNAi for Therapeutic Sales Volume and Market Share by Application

7 India RNAi for Therapeutic (Volume, Value and Sales Price)
    7.1 India RNAi for Therapeutic Sales and Value ( 2014-2019)
        7.1.1 India RNAi for Therapeutic Sales Volume and Growth Rate ( 2014-2019)
        7.1.2 India RNAi for Therapeutic Revenue and Growth Rate ( 2014-2019)
        7.1.3 India RNAi for Therapeutic Sales Price Trend ( 2014-2019)
    7.2 India RNAi for Therapeutic Sales Volume and Market Share by Type
    7.3 India RNAi for Therapeutic Sales Volume and Market Share by Application

8 Southeast Asia RNAi for Therapeutic (Volume, Value and Sales Price)
    8.1 Southeast Asia RNAi for Therapeutic Sales and Value ( 2014-2019)
        8.1.1 Southeast Asia RNAi for Therapeutic Sales Volume and Growth Rate ( 2014-2019)
        8.1.2 Southeast Asia RNAi for Therapeutic Revenue and Growth Rate ( 2014-2019)
        8.1.3 Southeast Asia RNAi for Therapeutic Sales Price Trend ( 2014-2019)
    8.2 Southeast Asia RNAi for Therapeutic Sales Volume and Market Share by Type
    8.3 Southeast Asia RNAi for Therapeutic Sales Volume and Market Share by Application

9 Australia RNAi for Therapeutic (Volume, Value and Sales Price)
    9.1 Australia RNAi for Therapeutic Sales and Value ( 2014-2019)
        9.1.1 Australia RNAi for Therapeutic Sales Volume and Growth Rate ( 2014-2019)
        9.1.2 Australia RNAi for Therapeutic Revenue and Growth Rate ( 2014-2019)
        9.1.3 Australia RNAi for Therapeutic Sales Price Trend ( 2014-2019)
    9.2 Australia RNAi for Therapeutic Sales Volume and Market Share by Type
    9.3 Australia RNAi for Therapeutic Sales Volume and Market Share by Application

10 Asia-Pacific RNAi for Therapeutic Players/Suppliers Profiles and Sales Data
    10.1 Alnylam Pharmaceuticals
        10.1.1 Company Basic Information, Manufacturing Base and Competitors
        10.1.2 RNAi for Therapeutic Product Category, Application and Specification
            10.1.2.1 Product A
            10.1.2.2 Product B
        10.1.3 Alnylam Pharmaceuticals RNAi for Therapeutic Sales, Revenue, Price and Gross Margin ( 2014-2019)
        10.1.4 Main Business/Business Overview
    10.2 Arbutus Biopharma (Tekmira)
        10.2.1 Company Basic Information, Manufacturing Base and Competitors
        10.2.2 RNAi for Therapeutic Product Category, Application and Specification
            10.2.2.1 Product A
            10.2.2.2 Product B
        10.2.3 Arbutus Biopharma (Tekmira) RNAi for Therapeutic Sales, Revenue, Price and Gross Margin ( 2014-2019)
        10.2.4 Main Business/Business Overview
    10.3 Arrowhead Research
        10.3.1 Company Basic Information, Manufacturing Base and Competitors
        10.3.2 RNAi for Therapeutic Product Category, Application and Specification
            10.3.2.1 Product A
            10.3.2.2 Product B
        10.3.3 Arrowhead Research RNAi for Therapeutic Sales, Revenue, Price and Gross Margin ( 2014-2019)
        10.3.4 Main Business/Business Overview
    10.4 Dicerna Pharmaceuticals
        10.4.1 Company Basic Information, Manufacturing Base and Competitors
        10.4.2 RNAi for Therapeutic Product Category, Application and Specification
            10.4.2.1 Product A
            10.4.2.2 Product B
        10.4.3 Dicerna Pharmaceuticals RNAi for Therapeutic Sales, Revenue, Price and Gross Margin ( 2014-2019)
        10.4.4 Main Business/Business Overview
    10.5 Mirna Therapeutics
        10.5.1 Company Basic Information, Manufacturing Base and Competitors
        10.5.2 RNAi for Therapeutic Product Category, Application and Specification
            10.5.2.1 Product A
            10.5.2.2 Product B
        10.5.3 Mirna Therapeutics RNAi for Therapeutic Sales, Revenue, Price and Gross Margin ( 2014-2019)
        10.5.4 Main Business/Business Overview
    10.6 Quark Pharmaceuticals
        10.6.1 Company Basic Information, Manufacturing Base and Competitors
        10.6.2 RNAi for Therapeutic Product Category, Application and Specification
            10.6.2.1 Product A
            10.6.2.2 Product B
        10.6.3 Quark Pharmaceuticals RNAi for Therapeutic Sales, Revenue, Price and Gross Margin ( 2014-2019)
        10.6.4 Main Business/Business Overview
    10.7 RXi Pharmaceuticals
        10.7.1 Company Basic Information, Manufacturing Base and Competitors
        10.7.2 RNAi for Therapeutic Product Category, Application and Specification
            10.7.2.1 Product A
            10.7.2.2 Product B
        10.7.3 RXi Pharmaceuticals RNAi for Therapeutic Sales, Revenue, Price and Gross Margin ( 2014-2019)
        10.7.4 Main Business/Business Overview
    10.8 Silence Therapeutics
        10.8.1 Company Basic Information, Manufacturing Base and Competitors
        10.8.2 RNAi for Therapeutic Product Category, Application and Specification
            10.8.2.1 Product A
            10.8.2.2 Product B
        10.8.3 Silence Therapeutics RNAi for Therapeutic Sales, Revenue, Price and Gross Margin ( 2014-2019)
        10.8.4 Main Business/Business Overview
    10.9 Benitec Biopharma
        10.9.1 Company Basic Information, Manufacturing Base and Competitors
        10.9.2 RNAi for Therapeutic Product Category, Application and Specification
            10.9.2.1 Product A
            10.9.2.2 Product B
        10.9.3 Benitec Biopharma RNAi for Therapeutic Sales, Revenue, Price and Gross Margin ( 2014-2019)
        10.9.4 Main Business/Business Overview
    10.10 Miragen Therapeutics
        10.10.1 Company Basic Information, Manufacturing Base and Competitors
        10.10.2 RNAi for Therapeutic Product Category, Application and Specification
            10.10.2.1 Product A
            10.10.2.2 Product B
        10.10.3 Miragen Therapeutics RNAi for Therapeutic Sales, Revenue, Price and Gross Margin ( 2014-2019)
        10.10.4 Main Business/Business Overview
    10.11 Sylentis
    10.12 Gradalis
    10.13 Sirnaomics
    10.14 Silenseed
    10.15 Arcturus Therapeutics
    10.16 Ariz Biopharma
    10.17 Celsion Corporation
    10.18 Ascletis Pharmaceuticals

11 RNAi for Therapeutic Manufacturing Cost Analysis
    11.1 RNAi for Therapeutic Key Raw Materials Analysis
        11.1.1 Key Raw Materials
        11.1.2 Price Trend of Key Raw Materials
        11.1.3 Key Suppliers of Raw Materials
        11.1.4 Market Concentration Rate of Raw Materials
    11.2 Proportion of Manufacturing Cost Structure
        11.2.1 Raw Materials
        11.2.2 Labor Cost
        11.2.3 Manufacturing Expenses
    11.3 Manufacturing Process Analysis of RNAi for Therapeutic

12 Industrial Chain, Sourcing Strategy and Downstream Buyers
    12.1 RNAi for Therapeutic Industrial Chain Analysis
    12.2 Upstream Raw Materials Sourcing
    12.3 Raw Materials Sources of RNAi for Therapeutic Major Manufacturers  in 2018
    12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders
    13.1 Marketing Channel
        13.1.1 Direct Marketing
        13.1.2 Indirect Marketing
        13.1.3 Marketing Channel Development Trend
    13.2 Market Positioning
        13.2.1 Pricing Strategy
        13.2.2 Brand Strategy
        13.2.3 Target Client
    13.3 Distributors/Traders List

14 Market Effect Factors Analysis
    14.1 Technology Progress/Risk
        14.1.1 Substitutes Threat
        14.1.2 Technology Progress in Related Industry
    14.2 Consumer Needs/Customer Preference Change
    14.3 Economic/Political Environmental Change

15 Asia-Pacific RNAi for Therapeutic Market Forecast ( 2019-2025)
    15.1 Asia-Pacific RNAi for Therapeutic Sales Volume, Revenue and Price Forecast ( 2019-2025)
        15.1.1 Asia-Pacific RNAi for Therapeutic Sales Volume and Growth Rate Forecast ( 2019-2025)
        15.1.2 Asia-Pacific RNAi for Therapeutic Revenue and Growth Rate Forecast ( 2019-2025)
        15.1.3 Asia-Pacific RNAi for Therapeutic Price and Trend Forecast ( 2019-2025)
    15.2 Asia-Pacific RNAi for Therapeutic Sales Volume, Revenue and Growth Rate Forecast by Region ( 2019-2025)
        15.2.1 Asia-Pacific RNAi for Therapeutic Sales Volume and Growth Rate Forecast by Region ( 2019-2025)
        15.2.2 Asia-Pacific RNAi for Therapeutic Revenue and Growth Rate Forecast by Region ( 2019-2025)
        15.2.3 China RNAi for Therapeutic Sales, Revenue and Growth Rate Forecast ( 2019-2025)
        15.2.4 Japan RNAi for Therapeutic Sales, Revenue and Growth Rate Forecast ( 2019-2025)
        15.2.5 South Korea RNAi for Therapeutic Sales, Revenue and Growth Rate Forecast ( 2019-2025)
        15.2.6 Taiwan RNAi for Therapeutic Sales, Revenue and Growth Rate Forecast ( 2019-2025)
        15.2.7 India RNAi for Therapeutic Sales, Revenue and Growth Rate Forecast ( 2019-2025)
        15.2.8 Southeast Asia RNAi for Therapeutic Sales, Revenue and Growth Rate Forecast ( 2019-2025)
        15.2.9 Australia RNAi for Therapeutic Sales, Revenue and Growth Rate Forecast ( 2019-2025)
    15.3 Asia-Pacific RNAi for Therapeutic Sales, Revenue and Price Forecast by Type ( 2019-2025)
        15.3.1 Asia-Pacific RNAi for Therapeutic Sales Forecast by Type ( 2019-2025)
        15.3.2 Asia-Pacific RNAi for Therapeutic Revenue Forecast by Type ( 2019-2025)
        15.3.3 Asia-Pacific RNAi for Therapeutic Price Forecast by Type ( 2019-2025)
    15.4 Asia-Pacific RNAi for Therapeutic Sales Forecast by Application ( 2019-2025)

16 Research Findings and Conclusion

17 Appendix
    17.1 Methodology/Research Approach
        17.1.1 Research Programs/Design
        17.1.2 Market Size Estimation
        17.1.3 Market Breakdown and Data Triangulation
    17.2 Data Source
        17.2.1 Secondary Sources
        17.2.2 Primary Sources
    17.3 Disclaimer